StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

Investment analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX) in a report issued on Thursday. The firm set a “hold” rating on the software maker’s stock.

Veradigm Price Performance

Shares of MDRX stock opened at $9.05 on Thursday. Veradigm has a 1 year low of $5.01 and a 1 year high of $13.62. The firm’s fifty day simple moving average is $9.55 and its 200 day simple moving average is $9.10.

Institutional Investors Weigh In On Veradigm

Institutional investors have recently bought and sold shares of the business. Innealta Capital LLC acquired a new stake in shares of Veradigm in the 2nd quarter valued at $38,000. Meadow Creek Wealth Advisors LLC acquired a new position in Veradigm during the 1st quarter worth about $83,000. Tyro Capital Management LLC acquired a new position in Veradigm during the 1st quarter worth about $9,055,000. Goldman Sachs Group Inc. lifted its position in Veradigm by 6.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after buying an additional 99,528 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after buying an additional 95,291 shares in the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.